Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β‐Catenin Expression and Podocyte Epithelial‐Mesenchymal Transition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2017-05-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.26017PMID 28370212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes

  2018cited by this paper
• CTGF mediates high-glucose induced epithelial–mesenchymal transition through activation of β-catenin in podocytes

  2016cited by this paper
• Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?

  2015cited by this paper
• [Isolation and culture of renal glomeruli from rats].

  2015cited by this paper
• Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

  2015cited by this paper
• Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes

  2014cited by this paper
• A Glimpse of the Pathogenetic Mechanisms of Wnt/β-Catenin Signaling in Diabetic Nephropathy

  2013cited by this paper
• The roles of connective tissue growth factor and integrin‐linked kinase in high glucose‐induced phenotypic alterations of podocytes

  2012cited by this paper
• Podocytopathy in diabetes: a metabolic and endocrine disorder.

  2011cited by this paper
• Effects of Angiotensin Receptor Blocker on Phenotypic Alterations of Podocytes in Early Diabetic Nephropathy

  2011cited by this paper
• CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy

  2011cited by this paper
• Inhibition of Connective Tissue Growth Factor Overexpression in Diabetic Retinopathy by SERPINA3K via Blocking the WNT/β-Catenin Pathway

  2010cited by this paper
• New insights into epithelial-mesenchymal transition in kidney fibrosis.

  2010influential reference
• The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology

  2010cited by this paper
• Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

  2010cited by this paper
• Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.

  2009influential reference
• Wnt/beta-catenin signaling promotes renal interstitial fibrosis.

  2009cited by this paper
• Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.

  2009cited by this paper
• Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

  2008cited by this paper
• The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?

  2008cited by this paper
• Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.

  2008cited by this paper
• From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

  2005cited by this paper
• Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex

  2004cited by this paper
• Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

  2003cited by this paper
• Expression of connective tissue growth factor in human renal fibrosis.

  1998cited by this paper

• CircTHBS1 aggravates peritoneal fibrosis by sponging miR-18a-5p and interacting with CTGF.

  2026cites this paper
• Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease

  2025cites this paper
• The Non‐Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF‐β‐E2F1 Axis

  2025cites this paper
• Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets

  2024cites this paper
• Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy

  2022cites this paper
• Cellular phenotypic transitions in diabetic nephropathy: An update

  2022cites this paper
• Vaccination against connective tissue growth factor attenuates the development of renal fibrosis

  2022cites this paper
• Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases

  2022cites this paper
• Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice

  2021cites this paper
• Protective Effects of Ethanolic Extract from Rhizome of Polygoni avicularis against Renal Fibrosis and Inflammation in a Diabetic Nephropathy Model

  2021cites this paper
• Salidroside protects against diabetes mellitus‐induced kidney injury and renal fibrosis by attenuating TGF‐β1 and Wnt1/3a/β‐catenin signalling

  2020cites this paper
• Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications

  2020influential citation
• Investigating the role of connective tissue growth factor as a critical mediator of cryoglobulinaemic glomerulonephritis

  2019cites this paper
• Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue.

  2019cites this paper
• Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes

  2018cites this paper
• Connective tissue growth factor (CTGF) from basics to clinics.

  2018cites this paper
• Involvement of growth factors in diabetes mellitus and its complications: A general review.

  2018cites this paper